{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:36Z","timestamp":1756339536067,"version":"3.44.0"},"reference-count":6,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Neurofibromas are defined as benign tumours arising from peripheral nerve sheaths. Few intraoral palatal cases have been reported. Neurofibromas can occur as part of neurofibromatosis, type 1 (NF1) or type 2 (NF2). A 41-year-old patient presented with a slowly enlarging soft tissue mass on the hard palate. An incisional biopsy was performed, which confirmed the diagnosis of a neurofibroma associated with NF1. It should be considered that there is a chance of malignant transformation. Here, we discuss the clinical features, types, diagnosis, histopathology and treatment options.<\/jats:p>","DOI":"10.1136\/bcr-2020-239887","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:38:11Z","timestamp":1617802691000},"page":"e239887","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Neurofibroma of the hard palate"],"prefix":"10.1136","volume":"14","author":[{"given":"Bethany","family":"Cartwright","sequence":"first","affiliation":[{"name":"Oral and Maxillofacial Surgery, Pinderfields Hospital, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Corsar","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgery, Pinderfields Hospital, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"2025082709422990000_14.4.e239887.1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603227"},{"key":"2025082709422990000_14.4.e239887.2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2014.02.007","article-title":"Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review","volume":"91","author":"Javed","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025082709422990000_14.4.e239887.3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/dermatopathology8010003","article-title":"Type I neurofibromatosis: case report and review of the literature focused on oral and cutaneous lesions","volume":"8","author":"Buchholzer","year":"2021","journal-title":"Dermatopathology"},{"key":"2025082709422990000_14.4.e239887.4","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"2025082709422990000_14.4.e239887.5","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906"},{"key":"2025082709422990000_14.4.e239887.6","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.5.311"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-239887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:42:38Z","timestamp":1756312958000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-239887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,7]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-239887"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-239887","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}